Sectors · Healthcare & Life Sciences

Pharmaceuticals

Private financing across Pharmaceuticals, aggregated from public sources.

Pharmaceuticals is a subsector of Healthcare & Life Sciences. Zoom out to read the whole macro sector $400.1B raised across 15,258 companies.

$60.1B
Capital raised
1,610
Companies
4,106
Rounds
2005
First on record
2026-03-27
Latest round

Steady Pharmaceuticals drew $2.8B over the last 12 months, up 19% versus the prior 12 ($2.3B). Of 1,590 companies rankable against same-niche peers, 24% model over-valued and 30% under-valued.

Capital flow over time

Quarterly capital raised across Pharmaceuticals.

2008-Q1 · $242.6M2008-Q12008-Q2 · $7.8M2008-Q3 · $218.3M2008-Q4 · $78.8M2009-Q1 · $206.1M2009-Q2 · $926.9M2009-Q3 · $444.4M2009-Q4 · $1.1B2009-Q42010-Q1 · $530.8M2010-Q2 · $608.0M2010-Q3 · $584.6M2010-Q4 · $488.7M2011-Q1 · $834.8M2011-Q2 · $777.4M2011-Q3 · $388.2M2011-Q32011-Q4 · $693.9M2012-Q1 · $332.1M2012-Q2 · $373.7M2012-Q3 · $703.0M2012-Q4 · $660.3M2013-Q1 · $734.1M2013-Q2 · $860.9M2013-Q22013-Q3 · $425.1M2013-Q4 · $1.8B2014-Q1 · $1.0B2014-Q2 · $443.6M2014-Q3 · $511.0M2014-Q4 · $1.4B2015-Q1 · $617.2M2015-Q12015-Q2 · $623.2M2015-Q3 · $998.9M2015-Q4 · $1.4B2016-Q1 · $987.8M2016-Q2 · $4.3B2016-Q3 · $764.9M2016-Q4 · $497.2M2016-Q42017-Q1 · $376.4M2017-Q2 · $323.9M2017-Q3 · $1.1B2017-Q4 · $789.5M2018-Q1 · $820.2M2018-Q2 · $1.5B2018-Q3 · $1.0B2018-Q32018-Q4 · $1.1B2019-Q1 · $748.7M2019-Q2 · $1.7B2019-Q3 · $791.3M2019-Q4 · $555.2M2020-Q1 · $1.1B2020-Q2 · $493.0M2020-Q22020-Q3 · $1.1B2020-Q4 · $2.0B2021-Q1 · $1.5B2021-Q2 · $711.1M2021-Q3 · $1.0B2021-Q4 · $988.9M2022-Q1 · $267.3M2022-Q12022-Q2 · $711.7M2022-Q3 · $590.9M2022-Q4 · $1.0B2023-Q1 · $477.0M2023-Q2 · $505.8M2023-Q3 · $1.2B2023-Q4 · $498.1M2023-Q42024-Q1 · $867.4M2024-Q2 · $1.6B2024-Q3 · $329.8M2024-Q4 · $616.9M2025-Q1 · $705.0M2025-Q2 · $676.3M2025-Q3 · $416.9M2025-Q32025-Q4 · $1.8B2026-Q1 · $540.9M
Median round size by stage
StageMedian roundRounds
Growth/Late$549.3M14
Series D+$111.8M116
Series C$46.7M341
Series B$18.0M725
Series A$5.2M1,245
Seed$1.7M951
Pre-Seed$421K714
Top-funded companies
CompanyStageRaisedModeled value
AbbVie Inc.
North Chicago
Growth/Late$3.8B$138.2B
Salix Pharmaceuticals Ltd
Raleigh
Growth/Late$750.0M$27.3B
Catalent, Inc.
Somerset
Growth/Late$650.0M$23.6B
Sage Therapeutics, Inc.
CAMBRIDGE
Growth/Late$698.0M$20.7B
Akcea Therapeutics, Inc.
CAMBRIDGE
Growth/Late$543.2M$19.7B
Watson Pharmaceuticals Inc
CORONA
Growth/Late$500.0M$18.2B
Lyell Immunopharma, Inc.
SOUTH SAN FRANCISCO
Growth/Late$493.0M$17.9B
Moderna LLC
CAMBRIDGE
Growth/Late$691.1M$16.2B
Compound Holdings I, LLC
CHICAGO
Growth/Late$412.0M$15.0B
Nuvation Bio Inc.
NEW YORK
Series D+$275.3M$9.7B
Kv Pharmaceutical Co /De/
Chesterfield
Series D+$526.0M$9.2B
Recursion Pharmaceuticals, Inc.
SALT LAKE CITY
Series D+$478.3M$8.3B
Concordia International Corp.
Mississauga
Series D+$228.0M$8.1B
Immune Response BioPharma, Inc.
NEW YORK
Growth/Late$1.0B$7.6B
Bicycle Therapeutics Plc
CAMBRIDGE
Growth/Late$555.5M$7.3B
Vyripharm Enterprises, Inc.
HOUSTON
Series D+$300.0M$7.2B
Isis Pharmaceuticals Inc
CARLSBAD
Series D+$201.3M$7.1B
Verona Pharma plc
London
Series D+$244.7M$6.9B
Par Health, Inc.
St. Louis
Growth/Late$763.0M$6.8B
Clovis Oncology, Inc.
BOULDER
Series D+$358.3M$6.8B
Related sectors

Browse all sectors or the full company rankings.

Frequently asked
How much venture funding has the Pharmaceuticals sector raised?
Companies in Pharmaceuticals have raised approximately $60.1B across 4,106 recorded financing rounds among 1,610 companies, aggregated from public sources.
Is Pharmaceuticals venture funding growing?
Pharmaceuticals funding is currently steady: capital raised over the last 12 months was up 19% versus the prior 12 months.
What is the typical round size in Pharmaceuticals?
Median disclosed round sizes in Pharmaceuticals by stage are: Growth/Late $549.3M, Series D+ $111.8M, Series C $46.7M, Series B $18.0M. These are medians across recorded rounds, not averages.
Which are the most-funded Pharmaceuticals companies?
The most-funded Pharmaceuticals companies in our coverage include AbbVie Inc., Salix Pharmaceuticals Ltd, Catalent, Inc., Sage Therapeutics, Inc., Akcea Therapeutics, Inc.. See the full ranked table for disclosed capital and modeled valuations.
When did Pharmaceuticals funding activity begin in this data?
The earliest recorded Pharmaceuticals financing in our coverage dates to 2005, with the most recent round around 2026-03-27.